This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
5 High-Flying Stocks With Room to Run on Q3 Earnings This Week
by Nalak Das
Five companies namely, Danaher (DHR), PulteGroup (PHM), Penske Automotive (PAG), Mattel (MAT) and Altra Industrial Motion (AIMC) with a favorable Zacks Rank are poised to beat earnings estimates this week.
Danaher (DHR) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Danaher (DHR) have what it takes to be a top stock pick for momentum investors? Let's find out.
ITT vs. DHR: Which Stock Is the Better Value Option?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
5 Spectacular Earnings Charts
by Tracey Ryniec
These popular stocks have some of the best earnings charts of the week.
The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PPG, PG, Philip Morris, Northrop and Danaher
Danaher (DHR) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Danaher's (DHR) Q3 results are expected to reflect a healthy demand for products in Life Sciences and Diagnostics segments. Also, Cytiva is anticipated to have aided core sales.
Honeywell Ups UAS Scope With Ballard Unmanned Systems Buyout
by Zacks Equity Research
Honeywell's (HON) acquisition of Ballard Unmanned Systems is anticipated to enhance its product offerings in the unmanned aerial systems space. It will be part of Honeywell's Aerospace segment.
Buy 5 Corporate Giants Ahead of Earnings Results Next Week
by Nalak Das
Five corporate behemoths with a favorable Zacks Rank are poised to beat earnings estimates next week. Investment in these stocks will be fruitful at this stage.
Danaher (DHR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Macquarie (MIC) Displays Bright Prospects, Risks Persist
by Zacks Equity Research
Macquarie (MIC) stands to gain from solid demand for storage of petroleum products, growth projects and shareholder-friendly policies. The coronavirus outbreak-led market downturn remains a concern.
The Zacks Analyst Blog Highlights: Lennar Corp, Activision Blizzard, Danaher Corp, Installed Building Products and Galiano Gold
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lennar Corp, Activision Blizzard, Danaher Corp, Installed Building Products and Galiano Gold
Should You Buy Stocks Going into This Earnings Season?
by Sejuti Banerjea
Stick to tried and tested Zacks methodology this earnings season for valuable pointers as significant uncertainties remain.
Why the Earnings Surprise Streak Could Continue for Danaher (DHR)
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Danaher Restructure Debt With Senior Notes Issue & Redemption
by Zacks Equity Research
Danaher (DHR) issues senior notes worth $1 billion and uses proceeds to redeem Euro-denominated senior notes. The actions are likely to help in restructuring its debt profile.
3 Top Stocks From the Booming Diversified Operations Industry
by Payal Jalan
Notwithstanding the pandemic headwinds, the Zacks Diversified Operations industry seems to be leveraging benefits from the demand surge in the personal safety, medical equipment and defense markets. Three stocks, DHR, ITT and RAVN, are the likely outperformers from the sector.
ITT vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
Danaher (DHR) Prices Public Offering of $1B Senior Notes
by Zacks Equity Research
Danaher (DHR) prices $1 billion worth of senior note offerings. The net proceeds will be used for satisfying general corporate purposes.
3 Picks to Ride the Coronavirus-Led Strength in Lab Plastic Space
by Urmimala Biswas
These laboratory equipment suppliers' fate does not depend on the end result of the R&D outcomes of the drug and vaccine makers.
The Truth About Market Timing - September 29, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Danaher (DHR) Gains 19% in 3 Months: What's Driving It?
by Zacks Equity Research
Danaher (DHR), with a 19% rise in the past three months, benefits from core sales growth opportunities in Diagnostics and Life Sciences segments, innovation efforts, and shareholder-friendly policies.
General Electric Completes Gas Turbine Project in Nigeria
by Zacks Equity Research
General Electric's (GE) gas turbine rehabilitation project at NDPHC's 3 power plants will secure and restore the supply of up to 360-MW of electricity. It receives certification for its GE9X engine.
Honeywell's (HON) Board Okays 3.3% Hike in Dividend Rate
by Zacks Equity Research
Honeywell (HON), in sync with its shareholder-friendly policies, hikes the annual dividend rate by 3.3% or 12 cents per share.
3 Conglomerates to Shine Despite Pandemic-Led Uncertainties
by Payal Jalan
Amid the pandemic-stricken operating environment, conglomerates are benefiting from growth options within the defense, medical equipment, personal safety and other markets. We bring forth three suitable investment picks from the sector.
Bear of the Day: Mesa Labs (MLAB)
by Kevin Cook
Growth rates have stalled for this small-cap provider of quality control instruments for the medical sector